Status: Recruiting
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
The purpose of this study is to determine whether a regimen of high-dose immunoablative therapy will demonstrate safety that is consistent or improved with other published regimens in SSc patients, while maintaining a treatment effect.
Participants needed: 8
Trial details
Phase: Phase 2Age: 8-60Biological sex: AllType: InterventionalSponsor: Paul SzabolcsUpdated: Oct 15, 2025Locations: 3
Eligibility criteria
Patient, parent, or legal guardian must have given written informed consent. For... [+30]
New York Heart Association classification of heart failure ≥3. [+35]